Movements in Carrying Amounts Movement in the carrying amounts for each class of property, plant and equipment between the beginning and the end of the current financial year. The net carrying amount of goodwill can be analysed as follows:  A review of the carrying value of the goodwill which arose on the acquisition of Tacere Therapeutics Inc. was undertaken in the 2013 financial  year. The recoverable amounts of the cash generating units to which the goodwill was allocated were determined based on value-in-use  calculations. This review identified that the full value of the goodwill should be impaired and as such a non-cash impairment charge of $1,503,296  was booked in the 2013 financial year. Goodwill Impairment NOTE 13: GOODWILL 2014 2013 $ $ NOTE 12: PROPERTY, PLANT AND EQUIPMENT At cost  127,795  95,431 Accumulated depreciation  (80,118)  (67,311) Total Property, Plant and Equipment  47,677  28,120 Leasehold Plant and  Improvement Equipment Total  $ $ $ Balance at 30 June 2012  11,760  19,043  30,803 Additions - 27,111 27,111 Less Disposals  -  -  - Depreciation expense  (1,550)  (28,244)  (29,794) Balance at 30 June 2013  10,210  17,910  28,120 Additions - 32,365 32,365 Less Disposals  -  -  - Depreciation expense  (1,550)  (11,258)  (12,808) Balance at 30 June 2014 8,660  39,016  47,677 $ Gross carrying amount Balance at 30 June 2012 - Acquired through business combination 1,503,296 Balance at 30 June 2013 1,503,296  Acquired through business combination  -  Balance at 30 June 2014  1,503,296  Accumulated impairment Balance at 30 June 2012 - Impairment loss recognised in the year  (1,503,296) Balance at 30 June 2013 (1,503,296) Impairment loss recognised in the year  - Balance at 30 June 2014  (1,503,296)  Net book value At 30 June 2013  - As at 30 June 2014  - Page 32 Benitec Biopharma Ltd  Annual Report 2014 Notes to the Consolidated Financial Statements for the Year Ended 30 June 2014